 - Other concurrent diseasesabnormalities: A subject must not have any clinically significant, uncontrolled condition or disease state that, in the opinion of the investigator, would put the safety of the patient at risk through study participation if the conditiondisease exacerbated during the study. The investigator is encouraged to contact the study medical monitor if further clarification is required. 